The pharmaceutical industry occupies an unusually prominent position in discussions of IP policy and has been at the center of both domestic and international disputes over the interplay between IPRs, R&D incentives, price, and patient access. Despite the fervour of debate surrounding some key issues, there is comparatively little actual data to guide policy-making. This article reviews the empirical literature on intellectual property and pharmaceuticals, analyses methodological issues and important data sources, and outlines some of the most important research questions and knowledge gaps.
The Economic Impact of Patent Law in Pharmaceutical Industry: Issue, Challenges and Benefits
Publication Information
Journal Title: Asia Pacific Law & Policy Review
Author(s): Dr. Sushma Singh & Neetu Jain
Published On: 08/12/2023
Volume: 9
First Page: 93
Last Page: 125
ISSN: 2581-4095
Publisher: The Law Brigade Publisher
DOI Not Allotted [Get DOI]
Cite this Article
Dr. Sushma Singh & Neetu Jain, The Economic Impact of Patent Law in Pharmaceutical Industry: Issue, Challenges and Benefits, Volume 9, Asia Pacific Law & Policy Review, 93-125, Published on 08/12/2023, Available at https://aplpr.thelawbrigade.com/article/the-economic-impact-of-patent-law-in-pharmaceutical-industry-issue-challenges-and-benefits/
Abstract
Keywords: IP Policy, IPRs, R&D, Pharmaceutical Industry, incentives, Price, Patient Access
Share this research
© 2015 - 2024 All Rights Reserved by The Law Brigade Publishers
